UK-based company Derma-Seal has successfully obtained trademark registration of its post-treatment product in the UK and member states of the EU.
Mr Dalvi Humzah, consultant plastic, reconstructive and aesthetic surgeon and clinical director at Derma-Seal, said that following the company’s Commendation in The Barry Knapp Award for Product Innovation of the Year in last year’s Aesthetics Awards, the product has seen increased interest nationally and internationally.
Mr Humzah said, “Derma-Seal is used extensively in my practice following cannula treatments and Morpheus 8 treatments. My patients are delighted to be able to wear their makeup immediately following treatment and I am confident this spray prevents the entry of bacteria into the puncture sites.”
Alan Hillier, finance director at Derma-Seal added, “We have seen increased sales in the UK and Europe with interest in the Far East and the US. We are in discussion with key players in these new markets. We hope Derma-Seal will be of clinical use to practitioners there.”
Derma-Seal is available in the UK through distributors Church Pharmacy, John Bannon, You Can Pharmacy and Wigmore Medical.